VDyne, Inc. is a privately held medical device company headquartered in Maple Grove, Minnesota, focused on developing innovative solutions for tricuspid heart valve diseases.
Subscribe to see VDYNE, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
VDYNE, INC. is a company headquartered in United States. Its most recent funding round raised $8M in December 2020. Xcout tracks 13 named people at VDYNE, INC., including Mike Buck (Chief Executive Officer).
7 more named people on record for VDYNE, INC., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $8M | — | |
| Series C | $21M | 1 named | |
| SEC Form D filing | $13M | — | |
| SEC Form D filing | $6.8M | — | |
| SEC Form D filing | $5.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of VDYNE, INC.'s closest competitors — see the full list of competitors and alternatives →
Vascudyne, Inc. is a bioengineered tissue technology company specializing in cardiovascular medicine, including heart valve manufacturing and engineered tissue solutions.
NeoChord, Inc. is a privately held medical technology company headquartered in Maple Grove, Minnesota, specializing in medical equipment manufacturing and transforming mitral valve repair.
Trisol Medical is a medical equipment manufacturing company headquartered in Yokneam, Israel. The company specializes in the design and development of medical device concepts aimed at addressing unmet clinical needs in treating Tricuspid Valve insufficiency.
Innoventric is a medical device company founded in 2016 and headquartered in Rehovot, Israel, dedicated to addressing the complexities of tricuspid regurgitation with transcatheter solutions.
CroiValve is a Dublin-based medical technology company focused on developing minimally invasive heart valve devices, such as the DUO System, to treat tricuspid regurgitation.
Coramaze Technologies is a clinical and pre-commercial stage medical device company founded in 2013, with offices in Germany and Israel. The company is focused on developing an innovative transcatheter tricuspid valve repair system called TriPair.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.